1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-acquired infections (HAIs) Control Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Diagnostic techniques
1.2.3 Dleaning and sterilization
1.2.4 Treatment
1.3 Market by Application
1.3.1 Global Hospital-acquired infections (HAIs) Control Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 General Hospital
1.3.3 Infectious Disease Hospital
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hospital-acquired infections (HAIs) Control Market Perspective (2018-2030)
2.2 Hospital-acquired infections (HAIs) Control Growth Trends by Region
2.2.1 Hospital-acquired infections (HAIs) Control Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Hospital-acquired infections (HAIs) Control Historic Market Size by Region (2018-2023)
2.2.3 Hospital-acquired infections (HAIs) Control Forecasted Market Size by Region (2023-2030)
2.3 Hospital-acquired infections (HAIs) Control Market Dynamics
2.3.1 Hospital-acquired infections (HAIs) Control Industry Trends
2.3.2 Hospital-acquired infections (HAIs) Control Market Drivers
2.3.3 Hospital-acquired infections (HAIs) Control Market Challenges
2.3.4 Hospital-acquired infections (HAIs) Control Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital-acquired infections (HAIs) Control Players by Revenue
3.1.1 Global Top Hospital-acquired infections (HAIs) Control Players by Revenue (2018-2023)
3.1.2 Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Players (2018-2023)
3.2 Global Hospital-acquired infections (HAIs) Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital-acquired infections (HAIs) Control Revenue
3.4 Global Hospital-acquired infections (HAIs) Control Market Concentration Ratio
3.4.1 Global Hospital-acquired infections (HAIs) Control Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-acquired infections (HAIs) Control Revenue in 2022
3.5 Hospital-acquired infections (HAIs) Control Key Players Head office and Area Served
3.6 Key Players Hospital-acquired infections (HAIs) Control Product Solution and Service
3.7 Date of Enter into Hospital-acquired infections (HAIs) Control Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital-acquired infections (HAIs) Control Breakdown Data by Type
4.1 Global Hospital-acquired infections (HAIs) Control Historic Market Size by Type (2018-2023)
4.2 Global Hospital-acquired infections (HAIs) Control Forecasted Market Size by Type (2023-2030)
5 Hospital-acquired infections (HAIs) Control Breakdown Data by Application
5.1 Global Hospital-acquired infections (HAIs) Control Historic Market Size by Application (2018-2023)
5.2 Global Hospital-acquired infections (HAIs) Control Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Hospital-acquired infections (HAIs) Control Market Size (2018-2030)
6.2 North America Hospital-acquired infections (HAIs) Control Market Size by Country (2018-2023)
6.3 North America Hospital-acquired infections (HAIs) Control Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Hospital-acquired infections (HAIs) Control Market Size (2018-2030)
7.2 Europe Hospital-acquired infections (HAIs) Control Market Size by Country (2018-2023)
7.3 Europe Hospital-acquired infections (HAIs) Control Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size (2018-2030)
8.2 Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size by Country (2018-2023)
8.3 Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Hospital-acquired infections (HAIs) Control Market Size (2018-2030)
9.2 Latin America Hospital-acquired infections (HAIs) Control Market Size by Country (2018-2023)
9.3 Latin America Hospital-acquired infections (HAIs) Control Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size (2018-2030)
10.2 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Country (2018-2023)
10.3 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 STERIS Corporation
11.1.1 STERIS Corporation Company Detail
11.1.2 STERIS Corporation Business Overview
11.1.3 STERIS Corporation Hospital-acquired infections (HAIs) Control Introduction
11.1.4 STERIS Corporation Revenue in Hospital-acquired infections (HAIs) Control Business (2018-2023)
11.1.5 STERIS Corporation Recent Development
11.2 Advanced Sterilization Products Division
11.2.1 Advanced Sterilization Products Division Company Detail
11.2.2 Advanced Sterilization Products Division Business Overview
11.2.3 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Introduction
11.2.4 Advanced Sterilization Products Division Revenue in Hospital-acquired infections (HAIs) Control Business (2018-2023)
11.2.5 Advanced Sterilization Products Division Recent Development
11.3 Hoffmann-La Roche
11.3.1 Hoffmann-La Roche Company Detail
11.3.2 Hoffmann-La Roche Business Overview
11.3.3 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Introduction
11.3.4 Hoffmann-La Roche Revenue in Hospital-acquired infections (HAIs) Control Business (2018-2023)
11.3.5 Hoffmann-La Roche Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Hospital-acquired infections (HAIs) Control Introduction
11.4.4 Pfizer Revenue in Hospital-acquired infections (HAIs) Control Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 Becton Dickinson
11.5.1 Becton Dickinson Company Detail
11.5.2 Becton Dickinson Business Overview
11.5.3 Becton Dickinson Hospital-acquired infections (HAIs) Control Introduction
11.5.4 Becton Dickinson Revenue in Hospital-acquired infections (HAIs) Control Business (2018-2023)
11.5.5 Becton Dickinson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
